Skip to content

Inogen INGN Asset turnover

Asset turnover at other companies

ResMed logo
ResMedRMD
0.7×0.0×
AdaptHealth logo
AdaptHealthAHCO
0.7×0.0×
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
1.5×+0.1×
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
1.2×+0.2×
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
0.8×+0.1×

Other financials

Income statement

See full
Revenue$85.1M+3.4%
Gross profit$44.9M+1.7%
Operating income-$9.3M-21.9%
Net income-$8.3M-34.8%
EPS (diluted)-$0.30-20.0%

Balance sheet

See full
Cash & equivalents$93.1M-21.7%
Total debt$16.9M-11.9%
Total equity$182.9M-7.6%
Total assets$285.9M-7.3%

Cash flow

See full
Operating cash flow-$6.7M+60.2%
CapEx$210.0K-28.1%
Free cash flow-$6.9M+59.6%

Valuation

See full
Market cap$174.63M-9.7%
Enterprise value$98.45M-9.5%
P/S0.5×-0.1×

Profitability

See full
Gross margin52.8%-2.6pp
Operating margin-9.1%-0.8pp
Net margin-7.1%-0.8pp
FCF margin0.4%

Returns & leverage

See full
Return on equity-13.1%-0.9pp
Debt / equity0.1×0.0×
Current ratio3.1×0.0×

Where this comes from

Calculated from Inogen’s reported figures.

Based on trailing twelve months.

The official record: Inogen’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inogen's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inogen's asset turnover?
Inogen (INGN) reported asset turnover of 1.2× in Q1 2026.
How has Inogen's asset turnover changed year-over-year?
Inogen's asset turnover increased by 8.6% year-over-year, from 1.1× to 1.2×.
What is the long-term trend for Inogen's asset turnover?
Over 5 years (2020 to 2025), Inogen's asset turnover has grown at a 11.6% compound annual growth rate (CAGR), from 0.7× to 1.2×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.